Apoptotic endonuclease EndoG inhibits telomerase activity and induces malignant transformation of human CD4+ T cells


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Telomerase activity is regulated by an alternative splicing of mRNA of the telomerase catalytic subunit hTERT (human telomerase reverse transcriptase). Increased expression of the inactive spliced hTERT results in inhibition of telomerase activity. Little is known about the mechanism of hTERT mRNA alternative splicing. This study was aimed at determining the effect of an apoptotic endonuclease G (EndoG) on alternative splicing of hTERT and telomerase activity in CD4+ human T lymphocytes. Overexpression of EndoG in CD4+ T cells downregulated the expression of the active fulllength hTERT variant and upregulated the inactive alternatively spliced variant. Reduction of full-length hTERT levels caused downregulation of the telomerase activity, critical telomere shortening during cell division that converted cells into the replicative senescence state, activation of apoptosis, and finally cell death. Some cells survive and undergo a malignant transformation. Transformed cells feature increased telomerase activity and proliferative potential compared to the original CD4+ T cells. These cells have phenotype of T lymphoblastic leukemia cells and can form tumors and cause death in experimental mice.

About the authors

D. A. Vasina

Ecological Faculty

Email: zhdanovdd@mail.ru
Russian Federation, Moscow, 117198

D. D. Zhdanov

Ecological Faculty; Institute of Biomedical Chemistry

Author for correspondence.
Email: zhdanovdd@mail.ru
Russian Federation, Moscow, 117198; Moscow, 119121

E. V. Orlova

Institute of Theoretical and Experimental Biophysics

Email: zhdanovdd@mail.ru
Russian Federation, Pushchino, Moscow Region, 142290

V. S. Orlova

Ecological Faculty

Email: zhdanovdd@mail.ru
Russian Federation, Moscow, 117198

M. V. Pokrovskaya

Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Russian Federation, Moscow, 119121

S. S. Aleksandrova

Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Russian Federation, Moscow, 119121

N. N. Sokolov

Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Russian Federation, Moscow, 119121


Copyright (c) 2017 Pleiades Publishing, Ltd.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies